Prevalence, extent, and independent predictors of silent myocardial infarction

American Journal of Medicine

Volumn 126, Issue 6, 2013, Pages 515-522

  Arenja, Nisha ^a   Mueller, Christian ^a   Ehl, Niklas F ^a   Brinkert, Miriam ^a   Roost, Katharina ^a   Reichlin, Tobias ^a   Sou, Seoung Mann ^a   Hochgruber, Thomas ^a   Osswald, Stefan ^a   Zellweger, Michael J ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Diabetes mellitus; Myocardial perfusion single photon emission computed tomography Prevalence silent myocardial infarction

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MYOCARDIAL PERFUSION IMAGING; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; REST; SILENT MYOCARDIAL INFARCTION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

CHI-SQUARE DISTRIBUTION; DIABETES MELLITUS; DIAGNOSIS, DIFFERENTIAL; DYSLIPIDEMIAS; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; HYPERTENSION; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SMOKING; STATISTICS, NONPARAMETRIC; SWITZERLAND; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84878016910     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2012.11.028     Document Type: Article

References (30)

1. F. Van de Werf, J. Bax, and A. Betriu Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology Eur Heart J 29 2008 2909 2945
2. P.W. Armstrong, C.B. Granger, and P.X. Adams Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: a randomized controlled trial JAMA 297 2007 43 51
3. Assessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention (ASSENT-4 PCI) investigators Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI): randomised trial Lancet 367 2006 569 578
4. M.C. Stiles, E.R. Seaquist, and J.F. Yale Is silent myocardial infarction more common in women with type 2 diabetes than in men? J Diabetes Complications 26 2 2012 118 122
5. P. Valensi, L. Lorgis, and Y. Cottin Prevalence, incidence, predictive factors and prognosis of silent myocardial infarction: a review of the literature Arch Cardiovasc Dis 104 3 2011 178 188
6. C.Y. Loong, and C. Anagnostopoulos Diagnosis of coronary artery disease by radionuclide myocardial perfusion imaging Heart 90 Suppl 5 2004 v2 v9
7. D. Staub, C. Nusbaumer, and M.J. Zellweger Use of B-type natriuretic peptide in the detection of myocardial ischemia Am Heart J 151 2006 1223 1230
8. D. Staub, N.G. Morgenthaler, and C. Buser Use of copeptin in the detection of myocardial ischemia Clin Chim Acta 399 2009 69 73
9. D. Staub, N. Jonas, and M.J. Zellweger Use of N-terminal pro-B-type natriuretic peptide to detect myocardial ischemia Am J Med 118 2005 1287
10. N.F. Ehl, M. Kuhne, and M. Brinkert Diabetes reduces left ventricular ejection fraction-irrespective of presence and extent of coronary artery disease Eur J Endocrinol 165 2011 945 951
11. D.S. Berman, H. Kiat, and J.D. Friedman Separate acquisition rest thallium-201/stress technetium-99m sestamibi dual-isotope myocardial perfusion single-photon emission computed tomography: a clinical validation study J Am Coll Cardiol 22 1993 1455 1464
12. M.J. Zellweger, R. Hachamovitch, and X. Kang Threshold, incidence, and predictors of prognostically high-risk silent ischemia in asymptomatic patients without prior diagnosis of coronary artery disease J Nucl Cardiol 16 2009 193 200
13. R.J. Gibbons, G.J. Balady, and J.T. Bricker ACC/AHA 2002 guideline update for exercise testing: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines) Circulation 106 2002 1883 1892
14. M.J. Zellweger, C. Kaiser, and R. Jeger Coronary artery disease progression late after successful stent implantation J Am Coll Cardiol 59 9 2012 793 799
15. G.A. Diamond, H.M. Staniloff, and J.S. Forrester Computer-assisted diagnosis in the noninvasive evaluation of patients with suspected coronary artery disease J Am Coll Cardiol 1 1983 444 455
16. M.J. Zellweger, E.A. Dubois, and S. Lai Risk stratification in patients with remote prior myocardial infarction using rest-stress myocardial perfusion SPECT: prognostic value and impact on referral to early catheterization J Nucl Cardiol 9 2002 23 32
17. K.A. Ammar, S. Samee, and R. Makwana Echocardiographic characteristics of electrocardiographically unrecognized myocardial infarctions in a community population Am J Cardiol 96 2005 1069 1075
18. D. Lundblad, and M. Eliasson Silent myocardial infarction in women with impaired glucose tolerance: the Northern Sweden MONICA study Cardiovasc Diabetol 2 2003 9
19. N. Gopinath, U. Kaul, and S.L. Chadha Asymptomatic coronary heart disease detected on epidemiological survey of urban population of Delhi Indian Heart J 44 1992 95 98
20. A. Schomig, J. Mehilli, and D. Antoniucci Mechanical reperfusion in patients with acute myocardial infarction presenting more than 12 hours from symptom onset: a randomized controlled trial JAMA 293 2005 2865 2872
21. J. Nadelmann, W.H. Frishman, and W.L. Ooi Prevalence, incidence and prognosis of recognized and unrecognized myocardial infarction in persons aged 75 years or older: the Bronx Aging Study Am J Cardiol 66 1990 533 537
22. K. Yano, and C.J. MacLean The incidence and prognosis of unrecognized myocardial infarction in the Honolulu, Hawaii, Heart Program Arch Intern Med 149 1989 1528 1532
23. T.A. Kaandorp, J.J. Bax, and H.J. Lamb Which parameters on magnetic resonance imaging determine Q waves on the electrocardiogram? Am J Cardiol 95 2005 925 929
24. R.Y. Kwong, H. Sattar, and H. Wu Incidence and prognostic implication of unrecognized myocardial scar characterized by cardiac magnetic resonance in diabetic patients without clinical evidence of myocardial infarction Circulation 118 2008 1011 1020
25. Milan Study on Atherosclerosis and Diabetes (MiSAD) Group Prevalence of unrecognized silent myocardial ischemia and its association with atherosclerotic risk factors in noninsulin-dependent diabetes mellitus Am J Cardiol 79 1997 134 139
26. G. Vanzetto, S. Halimi, and T. Hammoud Prediction of cardiovascular events in clinically selected high-risk NIDDM patients. Prognostic value of exercise stress test and thallium-201 single-photon emission computed tomography Diabetes Care 22 1999 19 26
27. M.J. Zellweger, R. Hachamovitch, and X. Kang Prognostic relevance of symptoms versus objective evidence of coronary artery disease in diabetic patients Eur Heart J 25 2004 543 550
28. R.V. Jeger, P.O. Bonetti, and M.J. Zellweger Influence of revascularization on long-term outcome in patients > or =75 years of age with diabetes mellitus and angina pectoris Am J Cardiol 96 2005 193 198
29. C. Mueller, J.B. Mc Hodgson, and M. Brutsche Impact of intracoronary ultrasound guidance on long-term outcome of percutaneous coronary interventions in diabetics-insights from the randomized SIPS trial Swiss Med Wkly 132 2002 279 284
30. M.A. King, D.T. Long, and A.B. Brill SPECT volume quantitation: influence of spatial resolution, source size and shape, and voxel size Med Phys 18 1991 1016 1024